Los Angeles Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
45,909
+30,745
| +203% | +$1.5M | 0.01% | 434 |
|
|
2025
Q1 | $773K | Buy |
15,164
+34
| +0.2% | +$1.73K | ﹤0.01% | 635 |
|
|
2024
Q4 | $683K | Hold |
15,130
| – | – | ﹤0.01% | 729 |
|
|
2024
Q3 | $561K | Buy |
15,130
+4,325
| +40% | +$160K | ﹤0.01% | 830 |
|
|
2024
Q2 | $330K | Buy |
10,805
+5
| +0% | +$153 | ﹤0.01% | 982 |
|
|
2024
Q1 | $314K | Buy |
10,800
+2,024
| +23% | +$58.9K | ﹤0.01% | 986 |
|
|
2023
Q4 | $242K | Buy |
+8,776
| New | +$242K | ﹤0.01% | 1067 |
|
|
2023
Q3 | – | Sell |
-6,383
| Closed | -$260K | – | 1213 |
|
|
2023
Q2 | $260K | Buy |
6,383
+1,467
| +30% | +$59.7K | ﹤0.01% | 1049 |
|
|
2023
Q1 | $238K | Buy |
+4,916
| New | +$238K | ﹤0.01% | 1086 |
|
|
2021
Q2 | – | Sell |
-5,332
| Closed | -$252K | – | 1651 |
|
|
2021
Q1 | $252K | Sell |
5,332
-995
| -16% | -$47K | ﹤0.01% | 1479 |
|
|
2020
Q4 | $386K | Sell |
6,327
-9,608
| -60% | -$586K | ﹤0.01% | 1298 |
|
|
2020
Q3 | $745K | Sell |
15,935
-3,667
| -19% | -$171K | ﹤0.01% | 938 |
|
|
2020
Q2 | $995K | Buy |
19,602
+872
| +5% | +$44.3K | ﹤0.01% | 854 |
|
|
2020
Q1 | $836K | Buy |
18,730
+12,833
| +218% | +$573K | 0.01% | 758 |
|
|
2019
Q4 | $283K | Buy |
+5,897
| New | +$283K | ﹤0.01% | 1140 |
|
|
2019
Q3 | – | Sell |
-5,703
| Closed | -$257K | – | 1349 |
|
|
2019
Q2 | $257K | Buy |
+5,703
| New | +$257K | ﹤0.01% | 1230 |
|
|
2019
Q1 | – | Sell |
-8,823
| Closed | -$303K | – | 1418 |
|
|
2018
Q4 | $303K | Sell |
8,823
-670
| -7% | -$23K | ﹤0.01% | 1098 |
|
|
2018
Q3 | $446K | Buy |
+9,493
| New | +$446K | ﹤0.01% | 1129 |
|
|
2017
Q4 | – | Sell |
-11,460
| Closed | -$229K | – | 1373 |
|
|
2017
Q3 | $229K | Buy |
+11,460
| New | +$229K | ﹤0.01% | 1220 |
|